samedan logo
 
 
spacer
home > pmps > spring 2021 > procurement in a pandemic – building resilience into the pharma supply chain for 2021
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Procurement in a Pandemic – Building Resilience into the Pharma Supply Chain for 2021

The impact of the pandemic has seen some sectors left redundant in the wake of national lockdowns, while others have needed to scramble to keep up with demand unlike anything they have witnessed before. The pharmaceutical sector has been instrumental to the survival of not only people, but the businesses that keep our world turning. Now, as positive news around vaccines and the arrival of the cavalry paints its efforts in a strong light, you’d be forgiven for overlooking the strains involved with getting to this position, and certainly, how these strains are set to evolve over the coming months (1).

In truth, pharma hasn’t been impervious to the impacts of COVID-19. It hasn’t been the sole floating market in a sea of drowning enterprises. Rather, it has been submerged in a different way. While others have scrambled to keep up with new trends, fluctuating demand, and ever-changing regulations, the pharma industry has needed to pivot and flex in order to support the world in its darkest hour. Domestic efforts have tied into a global effort to diagnose, treat, and prevent the virus from spreading – as well as face the knock-on effects of a stretched healthcare system.

As a result of this sudden, interconnected activity, and amid a deluge of expectation, the pharma supply chain has faced undeniable pressure. The events of this year have revealed substantial vulnerabilities within the discipline that must be overcome to realise the promise of a vaccine and respond to increasingly complex healthcare demands in 2021 and beyond.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Melaye Ras-Work co-founded Efficio Consulting in 2000 with Alex Klein, Jens Pedersen, and Juraj Priecel after beginning her career at AT Kearney. She oversees projects spanning several geographies to deliver breakthrough transformations of clients’ procurement and supply chain operations. She also is leading Efficio’s growth in France.
spacer
Melaye Ras-Work
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

MyMD Pharmaceuticals Announces Issuance of U.S. Patent for Synthetic Cannabinoid Compounds for Treating Neuroinflammatory and Neurodegenerative Diseases

MyMD Pharmaceuticals Inc., a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms, today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 11,085,047 titled “Synthetic Cannabinoid Compounds for the Treatment of Substance Addiction and Other Disorders.”
More info >>

White Papers

Stripping the confusion out of PVC curtains... and a new seat range.

Teknomek Ltd

With the ever-growing trend towards modularisation of clean rooms and laboratories; Teknomek have responded with a new range of PVC strip curtains, suitable for use in environments where maintaining clean airflow is critical. This new PVC curtain range includes specialist perforated and electrostatic discharge alternatives to the standard options of clear and polar (-25oC) versions.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement